The increased expression of Oct-4 is strongly correlated with aggressive tumor behavior, including enhanced metastatic potential, therapy resistance, and poor prognosis across various cancers, including breast, ovarian, prostate, and lung cancers. The gene discussed is POU5F1; the disease is neoplasm.